Arruebo M, Vilaboa N, Sáez-Gutierrez B, Lambea J, Tres A, Valladares M, et al. Assessment of the evolution of cancer treatment therapies. Cancers. 2011;3(3):3279–330.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nussbaumer S, Bonnabry P, Veuthey J-L, Fleury-Souverain S. Analysis of anticancer drugs: a review. Talanta. 2011;85(5):2265–89.

Article  CAS  PubMed  Google Scholar 

Esfahani K, et al. A review of cancer immunotherapy: from the past, to the present, to the future. Curr Oncol. 2020;27(s2):87–97.

Article  Google Scholar 

Mei L, Zhang Z, Zhao L, Huang L, Yang X-L, Tang J, et al. Pharmaceutical nanotechnology for oral delivery of anti-cancer drugs. Adv Drug Deliv Rev. 2013;65(6):880–90.

Article  CAS  PubMed  Google Scholar 

Wolf CPJG, Rachow T, Ernst T, Hochhaus A, Zomorodbakhsch B, Foller S, et al. Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements. J Cancer Res Clin Oncol. 2021;148:1–13.

Google Scholar 

Khodavirdipour A, Zarean R, Safaralizadeh R. Evaluation of the anti-cancer effect of Syzygium cumini ethanolic extract on HT-29 colorectal cell line. J Gastrointest Cancer. 2021;52:575–81.

Article  CAS  PubMed  Google Scholar 

Bachmeier BE, Killian PH, Melchart D. The role of curcumin in prevention and management of metastatic disease. Int J Mol Sci. 2018;19(6):1716.

Article  PubMed  PubMed Central  Google Scholar 

Mansouri K, Rasoulpoor S, Daneshkhah A, Abolfathi S, Salari N, Mohammadi M, et al. Clinical effects of curcumin in enhancing cancer therapy: a systematic review. BMC Cancer. 2020;20:1–11.

Article  Google Scholar 

Dai J, Ashrafizadeh M, Aref AR, Sethi G, Ertas YN. Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy. Drug Discov Today. 2024;29(7):103981. https://doi.org/10.1016/j.drudis.2024.103981.

Article  CAS  PubMed  Google Scholar 

Islam MR, Islam F, Nafady MH, Akter M, Mitra S, Das R, et al. Natural small molecules in breast cancer treatment: understandings from a therapeutic viewpoint. Molecules. 2022;27(7):2165.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scazzocchio B, Minghetti L, D’Archivio M. Interaction between gut microbiota and curcumin: a new key of understanding for the health effects of curcumin. Nutrients. 2020;12(9):2499.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sabet S, Rashidinejad A, Melton LD, McGillivray DJ. Recent advances to improve curcumin oral bioavailability. Trends Food Sci Technol. 2021;110:253–66.

Article  CAS  Google Scholar 

Nair KL, Thulasidasan AK, Deepa G, Anto RJ, Kumar GS. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anti-cancer activity with dependence on the combination of the carrier. Int J Pharm. 2012;425(1–2):44–52.

Article  CAS  PubMed  Google Scholar 

Basniwal RK, Khosla R, Jain N. Improving the anti-cancer activity of curcumin using nanocurcumin dispersion in water. Nutr Cancer. 2014;66(6):1015–22.

Article  CAS  PubMed  Google Scholar 

Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, et al. Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): A novel strategy for human cancer therapy. J Nanobiotechnol. 2007;5:1.

Article  Google Scholar 

Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CG. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther. 2011;11(5):464–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prasanth R, Nair G, Girish CM. Enhanced endocytosis of nano-curcumin in nasopharyngeal cancer cells: AN atomic force microscopy study. Appl Physics Lett. 2011;99:16.

Article  Google Scholar 

Chaudhari PD, Kendre PN. Emerging trend in adressing the challenges to oral nanocurcumin delivery to improve quality of life of patients suffering from cancer. Indian Drugs. 2015;52(9):21–31.

Article  Google Scholar 

Dhivya R, Ranjani J, Rajendhran J, Rajasekaran M, Annaraj J. pH responsive curcumin/ZnO nanocomposite for drug delivery. Adv Mater Lett. 2015;6(6):505–12.

Article  CAS  Google Scholar 

Hossain DM, Panda AK, Chakrabarty S, Bhattacharjee P, Kajal K, Mohanty S, et al. MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu. Immunology. 2015;144(4):561–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu B, Sun D, Sun C, Sun YF, Sun HX, Zhu QF, et al. A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma. Biochem Biophys Res Commun. 2015;468(4):525–32.

Article  CAS  PubMed  Google Scholar 

Pillai JJ, Thulasidasan AKT, Anto RJ, Devika NC, Ashwanikumar N, Kumar GSV. Curcumin entrapped folic acid conjugated PLGA-PEG nanoparticles exhibit enhanced anti-cancer activity by site specific delivery. RSC Adv. 2015;5(32):25518–24.

Article  CAS  Google Scholar 

Xie M, Fan D, Zhao Z, Li Z, Li G, Chen Y, et al. Nano-curcumin prepared via supercritical: Improved anti-bacterial, anti-oxidant and anti-cancer efficacy. Int J Pharm. 2015;496(2):732–40.

Article  CAS  PubMed  Google Scholar 

Chamani F, Sadeghizadeh M, Masoumi M, Babashah S. Evaluation of miR-34 family and DNA methyltransferases 1, 3A, 3B gene expression levels in hepatocellular carcinoma following treatment with dendrosomal nanocurcumin. Asian Pac J Cancer Prev. 2016;17:219–24.

Article  PubMed  Google Scholar 

Keshavarz R, Bakhshinejad B, Babashah S, Baghi N, Sadeghizadeh M. Dendrosomal nanocurcumin and p53 overexpression synergistically trigger apoptosis in glioblastoma cells. Iran J Basic Med Sci. 2016;19(12):1353–62.

PubMed  PubMed Central  Google Scholar 

Khan MA, Zafaryab M, Mehdi SH, Ahmad I, Rizvi MM. Characterization and anti-proliferative activity of curcumin loaded chitosan nanoparticles in cervical cancer. Int J Biol Macromol. 2016;93(Pt A):242–53.

Article  CAS  PubMed  Google Scholar 

Khosropanah MH, Dinarvand A, Nezhadhosseini A, Haghighi A, Hashemi S, Nirouzad F, et al. Analysis of the anti-proliferative effects of curcumin and nanocurcumin in MDA-MB231 as a breast cancer cell line. Iranian J Pharmaceut Res. 2016;15(1):231–9.

CAS  Google Scholar 

Paunovic V, Ristic B, Markovic Z, Todorovic-Markovic B, Kosic M, Prekodravac J, et al. c-Jun N-terminal kinase-dependent apoptotic photocytotoxicity of solvent exchange-prepared curcumin nanoparticles. Biomed Microdevices. 2016;18:2.

Article  Google Scholar 

Aldahoun MA, Jaafar MS, Al-Akhras MAH, Bououdina M. Enhanced nanocurcumin toxicity against (PC3) tumor and microbial by using magnetic field in vitro. Artificial Cells Nanomed Biotechnol. 2017;45(4):843–53.

Article  CAS  Google Scholar 

Dash TK, Konkimalla VSB. Selection and optimization of nano-formulation of P-glycoprotein inhibitor for reversal of doxorubicin resistance in COLO205 cells. J Pharm Pharmacol. 2017;69(7):834–43.

Article  CAS  PubMed  Google Scholar 

Mahjoub MA, Bakhshinejad B, Sadeghizadeh M, Babashah S. Combination treatment with dendrosomal nanocurcumin and doxorubicin improves anti-cancer effects on breast cancer cells through modulating CXCR4/NF-kappa B/Smo regulatory network. Mol Biol Rep. 2017;44(4):341–51.

Article  CAS  PubMed  Google Scholar 

Mishra D, Iyyanki TS, Hubenak JR, Zhang Q, Mathur AB. Silk fibroin nanoparticles and cancer therapy. nanotechnology in cancer. Elsevier: Amsterdam; 2017.

Google Scholar 

Athira GK, Jyothi AN, Vishnu VR. Water soluble octenyl succinylated cassava starch-curcumin nano-formulation with enhanced bioavailability and anti-cancer potential. Starch-Starke. 2018;70:7–8.

Article  Google Scholar 

Bagheri R, Sanaat Z, Zarghami N. Synergistic effect of free and nano-encapsulated chrysin-curcumin on inhibition of hTERT gene expression in sw480 colorectal cancer cell line. Drug Res (Stuttg). 2018;68(6):335–43.

Article  CAS